drug · small molecule
DAYBUE STIX
updated 3mo agoby $ACAD ACADIA PHARMACEUTICALS INC🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for rett syndrome and 5 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying DAYBUE STIX
- phase3Open-Label Extension Study of Trofinetide for Rett Syndrome
- phase3An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
- phase3Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
- phase3Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)
News(1)
- On second try, Acadia drug gets nod from European regulatorsThe influential CHMP committee also threw its support behind more than a dozen other medicines while recommending the marketing authorization for Tavneos be revoked.biopharma_dive · 1mo ago
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that